Ionis Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
All right. Welcome, everyone. This is Josh Schimmer from Evercore ISI biotech team. Pleased to introduce management of Ionis Pharmaceuticals to our Fifth Annual Healthcare Conference. We have Onaiza Cadoret, Executive Vice President, Chief Global Product Strategy and Operations Officer -- sorry, Chief Global Product Strategy & Operations Officer; and Eugene Schneider, Executive Vice President and Chief Clinical Development Officer. So thanks so much for joining. There's so many moving parts that Ionis' had to talk about. So, I thought maybe we'd spend some time on the recent announcement of the Metagenomi partnership and just thinking about the strategy there and then maybe dive into some of the more later-stage emerging clinical programs.
Questions & Answers
So maybe just start with. So Ionis hosted a call to discuss the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |